ADNT three-lens brief
Evidence-based stock research on ADNT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +2.95% yesterday. · Trading at 12% of its 52-week range — deep in the lower band.
- Moved +2.95% yesterday.
- Trading at 12% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 16.5pp over 30 days.
- Analyst mean target $29.75 — 58% above current (12 analysts).
ADNT closed at $18.86 (+2.95%) as of 2026-09-11. Market cap: $1.45B. P/E (trailing) 33.1. Price is below the 50-day MA and below the 200-day MA. Positives: moved +2.95% yesterday.; analyst mean target $29.75 — 58% above current (12 analysts).. Concerns: trading at 12% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $3.93B, net income $25.00M, free cash flow $354.50M.
Why three lenses on ADNT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ADNTacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ADNT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ADNT brief"></iframe>